{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:55:14Z","timestamp":1789916114302,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Health and Care Research, Research for Patient Benefit Programme, United Kingdom","award":["NIHR201461"],"award-info":[{"award-number":["NIHR201461"]}]},{"name":"National Institute for Health and Care Research, Research for Patient Benefit Programme, United Kingdom","award":["NIHR201461"],"award-info":[{"award-number":["NIHR201461"]}]},{"name":"National Institute for Health and Care Research, Research for Patient Benefit Programme, United Kingdom","award":["NIHR201461"],"award-info":[{"award-number":["NIHR201461"]}]},{"name":"National Institute for Health and Care Research, Research for Patient Benefit Programme, United Kingdom","award":["NIHR201461"],"award-info":[{"award-number":["NIHR201461"]}]},{"name":"National Institute for Health and Care Research, Research for Patient Benefit Programme, United Kingdom","award":["NIHR201461"],"award-info":[{"award-number":["NIHR201461"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Significant concerns have been raised regarding how medications with a risk of dependence or withdrawal are managed and how care is experienced by patients. This study sought to co-design solutions to improve the experience of care for patients prescribed benzodiazepines, z-drugs, opioids for chronic non-cancer pain, gabapentinoids and antidepressants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Twenty patients and fifteen healthcare professionals from five different GP practices were recruited to take part. The study used Experience Based Co-Design. Patients and healthcare professionals completed semi-structured interviews and took part in feedback groups and co-design workshops to collaboratively identify priorities for improvement and to co-design solutions to improve the experience of care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Poor patient experience was common among people prescribed medications with a risk of dependence or withdrawal. Patients and healthcare professionals identified three main priority areas to improve the experience of care: (i) ensuring patients are provided with detailed information in relation to their medication, (ii) ensuring continuity of care for patients, and (iii) providing alternative treatment options to medication. Solutions to improve care were co-designed by patients and healthcare staff and implemented within participating GP practices to improve the experience of care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Good patient experience is a key element of quality care. This study highlights that the provision of in-depth medication related information, continuity of care and alternative treatment to medication are important to patients prescribed medicines with a risk of dependence or withdrawal. Improving these aspects of care should be a priority for future improvement and delivery plans.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-023-02253-9","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T09:02:12Z","timestamp":1704531732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improving patient experience for people prescribed medicines with a risk of dependence or withdrawal: co-designed solutions using experience based co-design"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-0902","authenticated-orcid":false,"given":"Jennifer","family":"Seddon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-4324","authenticated-orcid":false,"given":"Claire","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2158-0879","authenticated-orcid":false,"given":"Sarah","family":"Wadd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7669-0632","authenticated-orcid":false,"given":"Sion","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthea","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"key":"2253_CR1","volume-title":"Dependence and withdrawal associated with some prescribed medicines: an evidence review","author":"Public Health England","year":"2019","unstructured":"Public Health England. Dependence and withdrawal associated with some prescribed medicines: an evidence review. London: PHE.; 2019."},{"key":"2253_CR2","volume-title":"Prescribed Drugs associated with dependence and withdrawal \u2013 building a consensus for action","author":"British Medical Association","year":"2015","unstructured":"British Medical Association. Prescribed Drugs associated with dependence and withdrawal \u2013 building a consensus for action. London: BMA.; 2015."},{"key":"2253_CR3","volume-title":"Prescribing patterns in dependence forming medicines","author":"J Cartagena Farias","year":"2017","unstructured":"Cartagena Farias J, Porter L, McManus S, Strang J, Hickman M, Reed K, et al. Prescribing patterns in dependence forming medicines. London: NatCen.; 2017."},{"key":"2253_CR4","volume-title":"The patient Voice: an analysis of personal accounts of prescribed drug dependence and withdrawal submitted to petitions in Scotland and Wales","author":"A Guy","year":"2018","unstructured":"Guy A, Brown M, Lewis S. The patient Voice: an analysis of personal accounts of prescribed drug dependence and withdrawal submitted to petitions in Scotland and Wales. London: All-Party Parliamentary Group for Prescribed Drug Dependence.; 2018."},{"key":"2253_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.addbeh.2018.08.021","volume":"88","author":"J Read","year":"2019","unstructured":"Read J, Gee A, Diggle J, Butler H. Staying on, and coming off, antidepressants: the experiences of 752 UK adults. Addict Behav. 2019;88:82\u20135.","journal-title":"Addict Behav"},{"issue":"4","key":"2253_CR6","doi-asserted-by":"publisher","first-page":"e0284389","DOI":"10.1371\/journal.pone.0284389","volume":"18","author":"O Alabaku","year":"2023","unstructured":"Alabaku O, Yang A, Tharmarajah S, Suda K, Vigod S, Tadrous M. Global trends in antidepressant, atypical antipsychotic, and benzodiazepine use: a cross-sectional analysis of 64 countries. PLoS ONE. 2023;18(4):e0284389.","journal-title":"PLoS ONE"},{"issue":"8","key":"2253_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","volume":"378","author":"A Lembke","year":"2018","unstructured":"Lembke A, Papac J, Humphreys K. Our other prescription drug Problem. N Engl J Med. 2018;378(8):693\u20135.","journal-title":"N Engl J Med"},{"issue":"3","key":"2253_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.18553\/jmcp.2020.26.3.246","volume":"26","author":"NJ Pauly","year":"2020","unstructured":"Pauly NJ, Delcher C, Slavova S, Lindahl E, Talbert J, Freeman PR. Trends in gabapentin prescribing in a commercially insured US adult population, 2009\u20132016. J Managed care Specialty Pharm. 2020;26(3):246\u201352.","journal-title":"J Managed care Specialty Pharm"},{"issue":"7","key":"2253_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00228-014-1676-z","volume":"70","author":"V Abbing-Karahagopian","year":"2014","unstructured":"Abbing-Karahagopian V, Huerta C, Souverein PC, de Abajo F, Leufkens HGM, Slattery J, et al. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. 2014;70(7):849\u201357.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2253_CR10","first-page":"12452","volume":"74","author":"R Mojtabai","year":"2013","unstructured":"Mojtabai R, Olfson M. National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry. 2013;74(2):12452.","journal-title":"J Clin Psychiatry"},{"issue":"680","key":"2253_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3399\/bjgp19X701753","volume":"69","author":"KM Kennedy","year":"2019","unstructured":"Kennedy KM, O\u2019Riordan J. Prescribing benzodiazepines in general practice. Br J Gen Pract. 2019;69(680):152\u20133.","journal-title":"Br J Gen Pract"},{"issue":"2","key":"2253_CR12","first-page":"138","volume":"30","author":"Centers for Disease Control and Prevention","year":"2016","unstructured":"Centers for Disease Control and Prevention. Guideline for Prescribing opioids for Chronic Pain. J Pain Palliat Care Pharm. 2016;30(2):138\u201340.","journal-title":"J Pain Palliat Care Pharm"},{"key":"2253_CR13","unstructured":"National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. 2021."},{"key":"2253_CR14","unstructured":"National Institute for Health and Care Excellence. What issues should I be aware of when prescribing Z-drugs? NICE, Clinical Knowledge Summaries;; 2022."},{"key":"2253_CR15","volume-title":"Antidepressant withdrawal: a survey of patients\u2019 experience","author":"J Davies","year":"2018","unstructured":"Davies J, Pauli R, Montagu L, Lindsay R, Raymond-Barker B. Antidepressant withdrawal: a survey of patients\u2019 experience. London: The All-Party Parliamentary Group for Prescribed Drug Dependence.; 2018."},{"issue":"1","key":"2253_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.socscimed.2004.11.063","volume":"61","author":"P Pound","year":"2005","unstructured":"Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133\u201355.","journal-title":"Soc Sci Med"},{"issue":"3","key":"2253_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1192\/apt.bp.107.005165","volume":"16","author":"N Britten","year":"2010","unstructured":"Britten N, Riley R, Morgan M. Resisting psychotropic medicines: a synthesis of qualitative studies of medicine-taking. Adv Psychiatr Treat. 2010;16(3):207\u201318.","journal-title":"Adv Psychiatr Treat"},{"key":"2253_CR18","unstructured":"NHS Institute for Innovation and Improvement. The patient experience book. https:\/\/www.england.nhs.uk\/improvement-hub\/wp-content\/uploads\/sites\/44\/2017\/11\/Patient-Experience-Guidance-and-Support.pdf; 2013."},{"issue":"Supplement 1","key":"2253_CR19","doi-asserted-by":"publisher","first-page":"w555","DOI":"10.1377\/hlthaff.28.4.w555","volume":"28","author":"DM Berwick","year":"2009","unstructured":"Berwick DM. What \u2018Patient-Centered\u2019 should Mean: confessions of an Extremist. Health Aff. 2009;28(Supplement 1):w555\u2013w65.","journal-title":"Health Aff"},{"key":"2253_CR20","volume-title":"Measuring patient experience","author":"D de Silva","year":"2013","unstructured":"de Silva D. Measuring patient experience. London: The Health Foundation.; 2013."},{"key":"2253_CR21","doi-asserted-by":"publisher","first-page":"g2225","DOI":"10.1136\/bmj.g2225","volume":"348","author":"A Coulter","year":"2014","unstructured":"Coulter A, Locock L, Ziebland S, Calabrese J. Collecting data on patient experience is not enough: they must be used to improve care. BMJ: Br Med J. 2014;348:g2225.","journal-title":"BMJ: Br Med J"},{"issue":"1","key":"2253_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/qup0000196","volume":"9","author":"V Braun","year":"2022","unstructured":"Braun V, Clarke V. Conceptual and design thinking for thematic analysis. Qualitative Psychol. 2022;9(1):3\u201326.","journal-title":"Qualitative Psychol"},{"key":"2253_CR23","volume-title":"Analyzing qualitative data","author":"J Ritchie","year":"1994","unstructured":"Ritchie J, Spencer I. Qualitative data analysis for applied policy research. In: Bryman A, Burgess R, editors. Analyzing qualitative data. London: Routledge; 1994."},{"key":"2253_CR24","volume-title":"Involving people in their own health and care: statutory guidance for clinical commissioning groups and NHS England","author":"NHS England","year":"2017","unstructured":"NHS England. Involving people in their own health and care: statutory guidance for clinical commissioning groups and NHS England. London: NHS England; 2017."},{"key":"2253_CR25","volume-title":"Better care in my hands: a review of how people are involved in their care","author":"Care Quality Commission","year":"2016","unstructured":"Care Quality Commission. Better care in my hands: a review of how people are involved in their care. Newcastle: CQC.; 2016."},{"key":"2253_CR26","volume-title":"National Survey of GPs. The future of general practice","author":"British Medical Association","year":"2015","unstructured":"British Medical Association. National Survey of GPs. The future of general practice. London: BMA.; 2015."},{"key":"2253_CR27","volume-title":"Continuity of care and the patient experience","author":"G Freeman","year":"2010","unstructured":"Freeman G, Hughes J. Continuity of care and the patient experience. London: The Kings Fund.; 2010."},{"key":"2253_CR28","volume-title":"Good medical practice for General practitioners","author":"Royal College of General Practitioners","year":"2008","unstructured":"Royal College of General Practitioners. Good medical practice for General practitioners. London: RCGP; 2008."},{"issue":"6","key":"2253_CR29","doi-asserted-by":"publisher","first-page":"e021161","DOI":"10.1136\/bmjopen-2017-021161","volume":"8","author":"DJP Gray","year":"2018","unstructured":"Gray DJP, Sidaway-Lee K, White E, Thorne A, Evans PH. Continuity of care with doctors\u2014a matter of life and death? A systematic review of continuity of care and mortality. BMJ Open. 2018;8(6):e021161.","journal-title":"BMJ Open"},{"issue":"7425","key":"2253_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/bmj.327.7425.1219","volume":"327","author":"JL Haggerty","year":"2003","unstructured":"Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. BMJ. 2003;327(7425):1219\u201321.","journal-title":"BMJ"},{"issue":"5","key":"2253_CR31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1365-2753.2009.01235.x","volume":"16","author":"C Van Walraven","year":"2010","unstructured":"Van Walraven C, Oake N, Jennings A, Forster AJ. The association between continuity of care and outcomes: a systematic and critical review. J Eval Clin Pract. 2010;16(5):947\u201356.","journal-title":"J Eval Clin Pract"},{"key":"2253_CR32","volume-title":"The future of general practice. Fourth report of session 2022-23","author":"Health and Social Care Committee","year":"2022","unstructured":"Health and Social Care Committee. The future of general practice. Fourth report of session 2022-23. London: House of Commons; 2022."},{"key":"2253_CR33","volume-title":"GP patient survey","author":"NHS England","year":"2022","unstructured":"NHS England. GP patient survey. London: NHS England.; 2022."},{"issue":"649","key":"2253_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3399\/bjgp16X686185","volume":"66","author":"H Jeffers","year":"2016","unstructured":"Jeffers H, Baker M. Continuity of care: still important in modern-day general practice. Br J Gen Pract. 2016;66(649):396\u20137.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"2253_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2296-14-191","volume":"14","author":"C Sirdifield","year":"2013","unstructured":"Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN. General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract. 2013;14(1):191.","journal-title":"BMC Fam Pract"},{"issue":"13","key":"2253_CR36","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/archinte.168.13.1404","volume":"168","author":"HN Young","year":"2008","unstructured":"Young HN, Bell RA, Epstein RM, Feldman MD, Kravitz RL. Physicians\u2019 Shared decision-making behaviors in Depression Care. Arch Intern Med. 2008;168(13):1404\u20138.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2253_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/fampra\/18.1.84","volume":"18","author":"J Wilson","year":"2001","unstructured":"Wilson J, Read J. What prevents GPs from using outside resources for women experiencing depression? A New Zealand study. Fam Pract. 2001;18(1):84\u20136.","journal-title":"Fam Pract"},{"issue":"4","key":"2253_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/02813430701726335","volume":"25","author":"S Anthierens","year":"2007","unstructured":"Anthierens S, Habraken H, Petrovic M, Christiaens T. The lesser evil? Initiating a benzodiazepine prescription in general practice. Scand J Prim Health Care. 2007;25(4):214\u20139.","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"2253_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2753\/IMH0020-7411430105","volume":"43","author":"K Gibson","year":"2014","unstructured":"Gibson K, Cartwright C, Read J. Patient-centered perspectives on antidepressant use. Int J Mental Health. 2014;43(1):81\u201399.","journal-title":"Int J Mental Health"},{"key":"2253_CR40","doi-asserted-by":"publisher","first-page":"p71","DOI":"10.1136\/bmj.p71","volume":"380","author":"C Pope","year":"2023","unstructured":"Pope C. NHS waiting times: a government pledge. BMJ. 2023;380:p71.","journal-title":"BMJ"},{"issue":"5","key":"2253_CR41","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2105\/AJPH.2012.300708","volume":"102","author":"VL Shavers","year":"2012","unstructured":"Shavers VL, Klein WMP, Fagan P. Research on Race\/Ethnicity and Health Care discrimination: where we are and where we need to go. Am J Public Health. 2012;102(5):930\u20132.","journal-title":"Am J Public Health"},{"key":"2253_CR42","volume-title":"Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults","author":"National Institute for Health and Care Excellence","year":"2022","unstructured":"National Institute for Health and Care Excellence. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults. London: NICE.; 2022."},{"key":"2253_CR43","volume-title":"Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care","author":"NHS England","year":"2023","unstructured":"NHS England. Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care. London: NHS England.; 2023."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02253-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-023-02253-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02253-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T21:15:10Z","timestamp":1704575710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-023-02253-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1186\/s12875-023-02253-9","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHS ethical approval was granted from Leicester Central Research Ethics Committee (21\/EM\/0116). Informed consent was obtained from all participants prior to participation in the study. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}